Supplementary Table S1-19 from Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations

Supplementary Table S1-19 from Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations

<p>Supplementary Table S1-19</p>

Uloženo v:

Podrobná bibliografie
Hlavní autor:	Yuxi Liu (15293121) (author)
Další autoři:	Alexander Gusev (11666368) (author), Peter Kraft (12074932) (author)
Vydáno:	2025
Témata:	Cancer Cancer Biology Molecular and Cellular Biology Immuno-oncology Clinical Research and Trials Epidemiology Carcinogenesis Mutagenesis Gene Regulation Genetics of Cancer Risk & Outcome Immunotherapy Oncogenes & Tumor Suppressors Precision Medicine
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky

Supplementary Tables from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
Autor: Weisi Liu (14963321)
Vydáno: (2025)

Supplementary Video from The Cytidine Deaminase APOBEC3G Contributes to Cancer Mutagenesis and Clonal Evolution in Bladder Cancer
Autor: Weisi Liu (14963321)
Vydáno: (2025)

Supplementary Tables S1-S12 from Gene-Level Germline Contributions to Clinical Risk of Recurrence Scores in Black and White Patients with Breast Cancer
Autor: Achal Patel (5853731)
Vydáno: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
Autor: Sami Belhadj (15052341)
Vydáno: (2025)

Supplementary Data from Genetic Modulation of <i>BET1L</i> Confers Colorectal Cancer Susceptibility by Reducing miRNA Binding and m<sup>6</sup>A Modification
Autor: Shuwei Li (16437116)
Vydáno: (2025)

Supplementary Tables 1 from Proteostasis Modulation in Germline Missense von Hippel Lindau Disease
Autor: Prashant Chittiboina (15367044)
Vydáno: (2025)

Supplementary Table 19 from Genetic Ancestry Inference from Cancer-Derived Molecular Data across Genomic and Transcriptomic Platforms
Autor: Pascal Belleau (14960153)
Vydáno: (2025)

Table S19 from Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma
Autor: Zhenyuan Yu (14962287)
Vydáno: (2025)

Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Autor: Erwei Zeng (14958443)
Vydáno: (2025)

Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Autor: Erwei Zeng (14958443)
Vydáno: (2025)

Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Autor: Erwei Zeng (14958443)
Vydáno: (2025)

Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Autor: Erwei Zeng (14958443)
Vydáno: (2025)

Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Autor: Erwei Zeng (14958443)
Vydáno: (2025)

Table S1 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Autor: Lenka Stolarova (16547259)
Vydáno: (2025)

Table S2 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Autor: Lenka Stolarova (16547259)
Vydáno: (2025)

Table S3 from ENIGMA <i>CHEK2</i>gether Project: A Comprehensive Study Identifies Functionally Impaired <i>CHEK2</i> Germline Missense Variants Associated with Increased Breast Cancer Risk
Autor: Lenka Stolarova (16547259)
Vydáno: (2025)

Supplementary Figure S1 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S10 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S11 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S12 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S2 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S4 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S5 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S6 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S7 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S8 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Supplementary Figure S9 from Elucidating the Genetic Landscape of Oral Leukoplakia to Predict Malignant Transformation
Autor: Leon J. Wils (15055780)
Vydáno: (2025)

Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Figure 2 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Figure 3 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Figure 4 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Figure 5 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Table 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Autor: Alba L. Combita (22677298)
Vydáno: (2025)

Supplementary Data- Tables TS1-6 from Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management
Autor: Rose B. McGee (15056564)
Vydáno: (2025)

Table S1 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Table S2 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Table S3 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Table S4 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Table S5 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Table S6 from Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection
Autor: Nina Rao (15321199)
Vydáno: (2025)

Cannot write session to /tmp/vufind_sessions/sess_rttdn3kjav7j139qoskmpp8395